{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:57:16Z","timestamp":1758121036567,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12958-017-0263-4","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T09:25:30Z","timestamp":1497259530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Differences in utilization of Intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S."],"prefix":"10.1186","volume":"15","author":[{"given":"Pavel","family":"Zagadailov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy E.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"issue":"3","key":"263_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/14647270903176773","volume":"12","author":"PR Brinsden","year":"2009","unstructured":"Brinsden PR, Brinsden PR. Thirty years of IVF: the legacy of Patrick Steptoe and Robert Edwards. Hum Fertil (Camb). 2009;12(3):137\u201343.","journal-title":"Hum Fertil (Camb)"},{"key":"263_CR2","unstructured":"Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2014 Assisted Reproductive Technology National Summary Report. Atlanta (GA): US Dept of Health and Human Services; 2016. \nftp:\/\/ftp.cdc.gov\/pub\/Publications\/art\/ART-2014-Clinic-Report-Full.pdf\n\n. Accessed 4\/6\/2017."},{"issue":"12","key":"263_CR3","doi-asserted-by":"publisher","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","volume":"9","author":"MN Mascarenhas","year":"2012","unstructured":"Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9(12):e1001356. \nhttp:\/\/dx.doi.org\/10.1371\/journal.pmed.1001356","journal-title":"PLoS Med"},{"issue":"4","key":"263_CR4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1389201017666160118103147","volume":"17","author":"A Pacchiarotti","year":"2016","unstructured":"Pacchiarotti A, Selman H, Valeri C, Napoletano S, Sbracia M, Antonini G, et al. Ovarian stimulation protocol in IVF: an up-to-date review of the literature. Curr Pharm Biotechnol. 2016;17(4):303\u201315.","journal-title":"Curr Pharm Biotechnol"},{"issue":"10","key":"263_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3978\/j.issn.2305-5839.2015.04.09","volume":"3","author":"D Shrestha","year":"2015","unstructured":"Shrestha D, La X, Feng HL. Comparison of different stimulation protocols used in in vitro fertilization: a review. Ann Transl Med. 2015;3(10):137. doi:\n10.3978\/j.issn.2305-5839.2015.04.09\n\n.","journal-title":"Ann Transl Med"},{"key":"263_CR6","doi-asserted-by":"publisher","first-page":"CD006919","DOI":"10.1002\/14651858.CD006919.pub4","volume":"11","author":"CS Siristatidis","year":"2015","unstructured":"Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database Syst Rev. 2015;11:CD006919. doi:\n10.1002\/14651858.CD006919.pub4\n\n.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"263_CR7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10815-016-0768-3","volume":"33","author":"A Capalbo","year":"2016","unstructured":"Capalbo A, Romanelli V, Cimadomo D, Girardi L, Stoppa M, Dovere L, et al. Implementing PGD\/PGD-A in IVF clinics: considerations for the best laboratory approach and management. J Assist Reprod Genet. 2016;33(10):1279\u201386.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"263_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10815-014-0372-3","volume":"32","author":"M Chawla","year":"2015","unstructured":"Chawla M, Fakih M, Shunnar A, Bayram A, Hellani A, Perumal V, et al. Morphokinetic analysis of cleavage stage embryos and its relationship to aneuploidy in a retrospective time-lapse imaging study. J Assist Reprod Genet. 2015;32(1):69\u201375.","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl 1","key":"263_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09513590.2014.945763","volume":"30","author":"MG Gryshchenko","year":"2014","unstructured":"Gryshchenko MG, Pravdyuk AI, Parashchyuk VY. Analysis of factors influencing morphokinetic characteristics of embryos in ART cycles. Gynecol Endocrinol. 2014;30(Suppl 1):6\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"263_CR10","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1093\/humrep\/der241","volume":"26","author":"A Sazonova","year":"2011","unstructured":"Sazonova A, K\u00e4llen K, Thurin-kjellberg A, Wennerholm UB, Bergh C. Factors affecting obstetric outcome of singletons born after IVF. Hum Reprod. 2011;26(10):2878\u201386.","journal-title":"Hum Reprod"},{"issue":"3","key":"263_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2014.17985","volume":"313","author":"SL Boulet","year":"2015","unstructured":"Boulet SL, Mehta A, Kissen DM, Warner L, Kawwass JF, Jamieson DJ. Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection. JAMA. 2015;313(3):255\u201363.","journal-title":"JAMA"},{"key":"263_CR12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/humupd\/dmn032","volume":"14","author":"AN Andersen","year":"2008","unstructured":"Andersen AN, Carlsen E, Loft A. Trends in the use of intracytoplasmatic sperm injection marked variability between countries. Hum Reprod Update. 2008;14:593\u2013604.","journal-title":"Hum Reprod Update"},{"key":"263_CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMsa070707","volume":"357","author":"T Jain","year":"2007","unstructured":"Jain T, Gupta RS. Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med. 2007;357:251\u20137.","journal-title":"N Engl J Med"},{"key":"263_CR14","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/humrep\/dew247","volume":"31","author":"FW Grimstad","year":"2016","unstructured":"Grimstad FW, Nangia AK, Luke B, Stern JE, Mak W. Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates. Hum Reprod. 2016;31:2750\u20135.","journal-title":"Hum Reprod"},{"key":"263_CR15","first-page":"21593","volume":"8","author":"L Ming","year":"2015","unstructured":"Ming L, Yuan C, Ping Z, Ping L, Jie Q. Conventional in vitro fertilization maybe yields more available embryos than intracytoplasmic sperm injection for patients with no indications for ICSI. Int J Clin Exp Med. 2015;8:21593\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"263_CR16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.fertnstert.2014.06.043","volume":"102","author":"SF Butts","year":"2014","unstructured":"Butts SF, Owen C, Mainigi M, Senapati S, Seifer DB, Dokras A. Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011. Fertil Steril. 2014;102:1041\u20137.","journal-title":"Fertil Steril"},{"issue":"2","key":"263_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10815-012-9922-8","volume":"230","author":"A Komsky-Elbaz","year":"2013","unstructured":"Komsky-Elbaz A, Raziel A, Friedler S, Strassburger D, Kasterstein E, Komarovsky D, et al. Conventional IVF versus ICSI in sibling oocytes from couples with endometriosis and normozoospermic semen. J Assist Reprod Genet. 2013l;230(2):251\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"263_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.fertnstert.2014.10.042","volume":"103","author":"S Kiatpongsan","year":"2015","unstructured":"Kiatpongsan S, Huckman RS, Hornstein MD. The Great recession, insurance mandates, and the use of in vitro fertilization services in the United States. Fertil Steril. 2015;103(2):448\u201354.","journal-title":"Fertil Steril"},{"issue":"11","key":"263_CR19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1701-2163(16)35436-6","volume":"34","author":"CA Jones","year":"2012","unstructured":"Jones CA, Gray L, Liu K. Fertility treatment decision-making: the effect of insurance coverage for fertility medications. J Obstet Gynaecol Can. 2012;34(11):1066\u201372.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"263_CR20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.fertnstert.2010.06.030","volume":"95","author":"JR Martin","year":"2011","unstructured":"Martin JR, Bromer JG, Sakkas D, Patrizio P. Insurance coverage and in vitro fertilization outcomes: a U.S. perspective. Fertil Steril. 2011;95(3):964\u20139.","journal-title":"Fertil Steril"},{"issue":"4","key":"263_CR21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.fertnstert.2009.06.020","volume":"94","author":"AD Domar","year":"2010","unstructured":"Domar AD, Smith K, Conboy L, Iannone M, Alper M. A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment. Fertil Steril. 2010;94(4):1457\u20139.","journal-title":"Fertil Steril"},{"issue":"9","key":"263_CR22","first-page":"570","volume":"42","author":"DA Hidlebaugh","year":"1997","unstructured":"Hidlebaugh DA, Thompson IE, Berger MJ. Cost of assisted reproductive technologies for a health maintenance organization. J Reprod Med. 1997;42(9):570\u20134.","journal-title":"J Reprod Med"},{"key":"263_CR23","unstructured":"Centers for Disease Control and Prevention. Assisted Reproductive Technology (ART). ART Success Rates. \nhttp:\/\/www.cdc.gov\/art\/excelfiles\/clinic_tables_data_2012.xls\n\n Accessed 7 Dec 2016."},{"key":"263_CR24","unstructured":"U.S. Department of Health & Human Services. Regional Offices. \nhttps:\/\/www.hhs.gov\/about\/agencies\/iea\/regional-offices\/\n\n Accessed 10 Dec 2016."},{"key":"263_CR25","unstructured":"America 2050. Regional planning association. \nhttp:\/\/www.america2050.org\/megaregions.html\n\n. Accessed 10 Dec 2016."}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-017-0263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T09:25:47Z","timestamp":1497259547000},"score":1,"resource":{"primary":{"URL":"http:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-017-0263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["263"],"URL":"https:\/\/doi.org\/10.1186\/s12958-017-0263-4","relation":{},"ISSN":["1477-7827"],"issn-type":[{"type":"electronic","value":"1477-7827"}],"subject":[],"published":{"date-parts":[[2017,6,12]]},"article-number":"45"}}